TAM
STSA

Tiverton Asset Management’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Tiverton Asset Management’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$125K Buy
+8,300
New +$129K ﹤0.01% 619

Other funds holding STSA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Tiverton Asset Management's STSA Position: Q3 2019 in Review

Tiverton Asset Management opened a new position in Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q3 2019: 8,300 shares worth $125K. The stake represents ﹤0.01% of the portfolio and ranks #619 among its holdings.

30 funds tracked by Wall St. Rank hold STSA as of Q3 2019.

  • Tiverton Asset Management held 8,300 shares of Satsuma Pharmaceuticals, Inc. Common Stock worth $125K as of Q3 2019.
  • Satsuma Pharmaceuticals, Inc. Common Stock was a new Tiverton Asset Management position in Q3 2019.
  • Satsuma Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #619 holding.
  • 30 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.